共 50 条
- [3] Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naive Patients With Crohn's Disease AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S571 - S572
- [4] Treatment Persistence Among Bio-naive Patients with Crohn's Disease Initiated on Ustekinumab and Adalimumab AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S328 - S329